• Aparito

Aparito's global impact on neuronopathic Gaucher Disease - White Paper

Here at Aparito we successfully used our remote technology to track the physical capabilities and emotional well being of patients with types 1 and 3 Gaucher Disease over several months. We believe that the data amassed with the use of our technology will benefit patients and their families greatly.

To read the full White Paper please click on the link below.

2020.0519 - Aparito's Global Impact on


© 2019 by Aparito | Privacy Policy